Altogether, our findings show that FOXA1 Class 1 mutations promoted by p53 inactivation trigger the formation of high-grade AR+ prostate adenocarcinoma that retain luminal features and regress upon castration, recapitulating cardinal characteristics of the primary human disease. The gene discussed is AR; the disease is prostate adenocarcinoma.